Biofilms and Chronic Inflammation without a Single-Disease Model

Abstract

In chronic pulmonary immune-dysregulation research, a convincing output can still be invalid when different respiratory conditions treated as biologically identical. This literature-based conceptual analysis does not report a new experiment. The starting source uses a review of biofilm interactions with innate and adaptive responses, including pattern recognition, extracellular traps, macrophage polarization, and T-cell differentiation. Similar inflammatory terms can describe different disease environments. Mechanisms depend on organisms, tissues, immune states, and treatment histories. Organize evidence by context and test proposed common mechanisms against discordant disease settings. Do not pool interventions merely because their labels sound similar. The proposed comparison concerns pulmonary diseases, biofilm structure, immune responses; it would test whether the specific failure scenario is detected without erasing legitimate uncertainty. The original source's limits remain material: Mechanisms vary across COPD, bronchiectasis, asthma, and other contexts; proposed combined antibiofilm/immunomodulatory strategies are not proven universal treatments.